ID: h-19689f6ce7
Hypothesis
GluN2B Tonic Activity Suppresses Glymphatic Perfusion Via Vasomotion Dysregulation
REVISED MECHANISM (post-Skeptic critique): Constitutive GluN2B signaling combined with age-related oxidative stress leads to excessive nNOS-derived superoxide and peroxynitrite (ONOO⁻) formation, causing vasomotor uncoupling, AQP4 oxidat.
🧬 GRIN2B (thalamocortical projection neurons); downstream: NOS1, AQP4🩺 neuroscience🎯 Composite 70%💱 $0.59▼14.5%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 2 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
REVISED MECHANISM (post-Skeptic critique): Constitutive GluN2B signaling combined with age-related oxidative stress leads to excessive nNOS-derived superoxide and peroxynitrite (ONOO⁻) formation, causing vasomotor uncoupling, AQP4 oxidation, and endothelial glycocalyx damage. Original NO-vasoconstriction mechanism was mechanistically flawed (NO produces vasodilation). Memantine data explained by reduced excitotoxic oxidative stress. Targeting downstream astrocyte/vascular pathways may be superior to direct GluN2B inhibition.
🧬 Mechanism
🔗 Mechanism from KG for GRIN2B (thalamocortical projection neurons); downstream: NOS1, AQP4
Auto-built from this analysis's top knowledge-graph edges.
graph TD
GluN2B["GluN2B"] -->|regulates| thalamic_burst_firing["thalamic burst firing"]
slow_wave_oscillations["slow-wave oscillations"] -->|enhances| glymphatic_clearance["glymphatic_clearance"]
tau_pathology["tau_pathology"] -.->|inhibits| glymphatic_clearance_effi["glymphatic clearance efficiency"]
Trem2["Trem2"] -->|regulates| tau_phagocytosis["tau phagocytosis"]
TREM2_deficiency["TREM2 deficiency"] -->|associated with| Tau_Clearance["Tau Clearance"]
Cx3Cl1["Cx3Cl1"] -->|associated with| Cx3Cr1["Cx3Cr1"]
Cx3Cr1_1["Cx3Cr1"] -->|regulates| tau_phagocytosis_2["tau phagocytosis"]
Memantine["Memantine"] -->|enhances| CSF_tracer_clearance["CSF tracer clearance"]
GluN2B_3["GluN2B"] -->|associated with| cortical_slow_wave_oscill["cortical slow-wave oscillations"]
oxidative_stress["oxidative_stress"] -->|causes| AQP4_oxidation["AQP4 oxidation"]
GLUTAMATE_EXCITOTOXICITY["GLUTAMATE EXCITOTOXICITY"] -->|enhances| Tau_Secretion["Tau Secretion"]
sess_SRB_2026_04_28_h_var["sess_SRB-2026-04-28-h-var-e2b5a7e7db_task_9aae8fc5"] -->|causal extracted| processed["processed"]
style GluN2B fill:#4fc3f7,stroke:#333,color:#000
style thalamic_burst_firing fill:#4fc3f7,stroke:#333,color:#000
style slow_wave_oscillations fill:#4fc3f7,stroke:#333,color:#000
style glymphatic_clearance fill:#81c784,stroke:#333,color:#000
style tau_pathology fill:#ef5350,stroke:#333,color:#000
style glymphatic_clearance_effi fill:#4fc3f7,stroke:#333,color:#000
style Trem2 fill:#4fc3f7,stroke:#333,color:#000
style tau_phagocytosis fill:#4fc3f7,stroke:#333,color:#000
style TREM2_deficiency fill:#4fc3f7,stroke:#333,color:#000
style Tau_Clearance fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cl1 fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cr1 fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cr1_1 fill:#4fc3f7,stroke:#333,color:#000
style tau_phagocytosis_2 fill:#4fc3f7,stroke:#333,color:#000
style Memantine fill:#ce93d8,stroke:#333,color:#000
style CSF_tracer_clearance fill:#ce93d8,stroke:#333,color:#000
style GluN2B_3 fill:#4fc3f7,stroke:#333,color:#000
style cortical_slow_wave_oscill fill:#4fc3f7,stroke:#333,color:#000
style oxidative_stress fill:#4fc3f7,stroke:#333,color:#000
style AQP4_oxidation fill:#4fc3f7,stroke:#333,color:#000
style GLUTAMATE_EXCITOTOXICITY fill:#4fc3f7,stroke:#333,color:#000
style Tau_Secretion fill:#4fc3f7,stroke:#333,color:#000
style sess_SRB_2026_04_28_h_var fill:#4fc3f7,stroke:#333,color:#000
style processed fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix2 supports3 contradicts
Contradicts
NO produces vasodilation, not vasoconstriction; original mechanism mechanistically unsound
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — GRIN2B
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GRIN2B (thalamocortical projection neurons); downstream: NOS1, AQP4.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 1.1%
Volatility
Low
0.0024
Events (7d)
3
Price History
▼14.5%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF aged thalamocortical projection neuron-specific GluN2B-overexpressing transgenic mice (CaMKII-Cre;GRIN2B-OE) are treated with either direct GluN2B antagonist (ifenprodil, 5 mg/kg, s.c., 14 days) OR | AQP4-MitoQ group: glymphatic clearance rate increases from baseline 0.015 min⁻¹ to ≥0.021 min⁻¹; ifenprodil group: clearance rate increases to ≤0.018 min⁻¹; sig | — no observation — | pending | 0.55 |
| IF aged (18-24 month) C57BL/6 mice with constitutive GluN2B overactivity receive selective nNOS inhibitor (ARL 17477, 10 mg/kg, i.p., 7 days) THEN glymphatic CSF influx into the cortex (measured by in | Significant increase in paravascular CSF tracer clearance rate (k_clearance) from 0.02 min⁻¹ baseline to ≥0.026 min⁻¹, with corresponding reduction in cortical | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF aged (18-24 month) C57BL/6 mice with constitutive GluN2B overactivity receive selective nNOS inhibitor (ARL 17477, 10 mg/kg, i.p., 7 days) THEN glymphatic CSF influx into the cortex (measured by in vivo 2-photon imaging of subarachnoid CSF- tracer AlexaFluor-647 conjugated albumin) will increase
Predicted outcome: Significant increase in paravascular CSF tracer clearance rate (k_clearance) from 0.02 min⁻¹ baseline to ≥0.026 min⁻¹, with corresponding reduction in
Falsification: No significant change in glymphatic tracer influx (<10% difference from vehicle) despite confirmed nNOS inhibition (assessed by reduced cerebellar nNOS activity via ELISA or reduced nitrite levels in
pendingconf 55%
IF aged thalamocortical projection neuron-specific GluN2B-overexpressing transgenic mice (CaMKII-Cre;GRIN2B-OE) are treated with either direct GluN2B antagonist (ifenprodil, 5 mg/kg, s.c., 14 days) OR downstream AQP4 oxidation protection (MitoQ, 10 mg/kg, i.p., 14 days) THEN downstream AQP4 protecti
Predicted outcome: AQP4-MitoQ group: glymphatic clearance rate increases from baseline 0.015 min⁻¹ to ≥0.021 min⁻¹; ifenprodil group: clearance rate increases to ≤0.018
Falsification: Falsified if ifenprodil produces equal or greater glymphatic improvement (>35% restoration) compared to MitoQ, OR if neither intervention produces significant improvement (>15% change from baseline),
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.